Moneycontrol PRO
HomeNewsStridespharmascience

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy NMDC, says Mitesh Thacker

    According to Mitesh Thacker of miteshthacker.com, one can buy NMDC and Strides Shasun.

  • Buy, sell or hold: 9 stocks that analysts are bullish on

    Buy, sell or hold: 9 stocks that analysts are bullish on

    Here are 9 stocks that brokerage firms' are bullish on. Morgan Stanley is overweight on Tata Motors with target price of Rs 585 per share. It expects volume to pick-up on XF launch in china & strong new discovery sales.

  • Sell Strides Shasun, India Cements; buy Vedanta: Ashwani Gujral

    Sell Strides Shasun, India Cements; buy Vedanta: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can sell Strides Shasun and India Cements and buy Vedanta.

  • Buy Coal India, Strides Arcolab: Sudarshan Sukhani

    Buy Coal India, Strides Arcolab: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one may buy Coal India and Strides Arcolab.

  • Buy Strides Shasun, IDBI Bank, Mindtree: Gaurav Bissa

    Buy Strides Shasun, IDBI Bank, Mindtree: Gaurav Bissa

    Gaurav Bissa of LKP Securities recommends buying Strides Shasun, IDBI Bank and Mindtree.

  • Bull's Eye: Buy Cox & Kings, Wockhardt, HDIL, Fortis Healthcare

    Bull's Eye: Buy Cox & Kings, Wockhardt, HDIL, Fortis Healthcare

    Ruchit Jain of Angel Broking recommends buying Cox & Kings with target of Rs 214 and IPCA Labs with target of Rs 604.

  • Buy Aurobindo Pharma, Stride Shasun, Torrent Pharma: Gujral

    Buy Aurobindo Pharma, Stride Shasun, Torrent Pharma: Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Aurobindo Pharma, Stride Shasun and Torrent Pharma.

  • Sell Strides Shasun, Larsen & Toubro: Ashwani Gujral

    Sell Strides Shasun, Larsen & Toubro: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends selling Strides Shasun and Larsen & Toubro.

  • Here are some stock trading ideas from Manoj Murlidharan

    Here are some stock trading ideas from Manoj Murlidharan

    In an interview to CNBC-TV18, Manoj Murlidharan of Religare Securities shared his readings and outlook on Futures and Options (F&O) side of the market, specific stocks and sectors.

  • Buy Arvind, UltraTech Cement, Edelweiss Financial: Gujral

    Buy Arvind, UltraTech Cement, Edelweiss Financial: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Arvind, UltraTech Cement and Edelweiss Financial.

  • Bull's Eye: Buy MRF, Federal Bank, Sun TV, IRB Infra, IGL

    Bull's Eye: Buy MRF, Federal Bank, Sun TV, IRB Infra, IGL

    Rakesh Bansal of RK Global suggests buying Indiabulls Housing Finance with a target of Rs 835.

  • NCC looks strong, sell Strides Shasun: CA Rudramurthy BV

    NCC looks strong, sell Strides Shasun: CA Rudramurthy BV

    CA Rudramurthy BV of Vachana Investments is of the view that NCC looks strong with a target of Rs 92 while he advises selling Strides Shasun.

  • Here are some trading picks from Mayuresh Joshi

    Here are some trading picks from Mayuresh Joshi

    Watch the interview of Mayuresh Joshi of Angel Broking with Latha Venkatesh, Anuj Singhal and Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

  • Investment strategies: 3 Bumper stocks to strike gold

    Investment strategies: 3 Bumper stocks to strike gold

    Credit Suisse maintains outperform on Strides Shasun expecting recovery in H2FY17. It has cut estimates by 30 percent/22 percent in 2017/18 to factor in API weakness. It says margin may hit 20 percent in second half with recovery in Africa business.

  • Buy Vedanta, Reliance Capital; sell Hexaware: Mitesh Thacker

    Buy Vedanta, Reliance Capital; sell Hexaware: Mitesh Thacker

    Mitesh Thackerof miteshthacker.com recommends buying Vedanta and Reliance Capital and advises selling Hexaware Technologies.

  • Sell HPCL, Strides Shasun; buy Tata Steel: Mitesh Thacker

    Sell HPCL, Strides Shasun; buy Tata Steel: Mitesh Thacker

    Mitesh Thacker of miteshthacker.com is of the view that one can sell Hindustan Petroleum Corporation and Strides Shasun and buy Tata Steel.

  • Tulsian on Ricoh India: Rush for exit, there is no hope

    Tulsian on Ricoh India: Rush for exit, there is no hope

    In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his reading and outlook on the fundamental side of the market as well as on specific stocks and sectors.

  • Here are SP Tulsian's top trading ideas

    Here are SP Tulsian's top trading ideas

    In an interview to CNBC-TV18's Anuj Singhal and Sonia Shenoy, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

  • Buy Sun Pharma, Lupin, Dr Reddy's Labs on declines: Gujral

    Buy Sun Pharma, Lupin, Dr Reddy's Labs on declines: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Lupin and Dr Reddy's Laboratories on declines.

  • Strides Shasun may test Rs 1350-1400: Ashwani Gujral

    Strides Shasun may test Rs 1350-1400: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that Strides Shasun may test Rs 1350-1400.

  • M&M, pharma stocks, Mahanagar Gas: See SP Tulsian's top picks

    M&M, pharma stocks, Mahanagar Gas: See SP Tulsian's top picks

    In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks for the day and talked about the listing of Mahanagar Gas on the Indian bourse.

  • Buy Strides Shasun, Axis Bank, Reliance Industries: Gujral

    Buy Strides Shasun, Axis Bank, Reliance Industries: Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Strides Shasun, Axis Bank and Reliance Industries.

  • Why pharma stocks can rally in July: SP Tulsian

    Why pharma stocks can rally in July: SP Tulsian

    In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he has a positive stance on all pharma stocks for this coming month.

  • SP Tulsian says pharma is theme for July series, go long in them

    SP Tulsian says pharma is theme for July series, go long in them

    I won‘t be surprised to see pharma as the story for July series and won‘t be surprised in seeing a big upsurge in all big pharma, said SP Tulsian.

  • Go long in Lupin, Glenmark, Strides Shasun: SP Tulsian

    Go long in Lupin, Glenmark, Strides Shasun: SP Tulsian

    SP Tulsian of sptulsian.com recommends going long in Lupin, Glenmark Pharma, Aurobindo Pharma and Strides Shasun.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347